When: November 16, 2015 (5:30-8:30 pm) Where: Hilton Baltimore, Baltimore, MD Instructors: Jim McNally, Ph.D., Associate Director, PDM Immunogenicity Expert, EMD Serono Amy Loercher, Ph.D., Manager, Clinical Immunology, GlaxoSmithKline This interactive session of intermediate level will focus on the potential challenges of immunogenicity testing in preclinical and clinical development and present case studies demonstrating how they can be handled. Attendees are encouraged to contribute with their own experiences and to bring questions for discussion or submit to the meeting organizers in advance. The following topics will be covered: * Challenges and approaches to resolve commonly encountered issues * Multi-domain binding proteins * Pre-existing ADAs * Emerging trends in the development of neutralizing antibody assays * Cross-reactivity to endogenous proteins * Clinical implications of ADAs This short course will be held at CHI's Seventh Annual Immunogenicity and Bioassay Summit 2015.

1. DINNER SHORT COURSE
ANNOUNCEMENT
The following topics will be covered:
• Challenges and approaches to resolve commonly
encountered issues
• Multi-domain binding proteins
• Pre-existing ADAs
• Emerging trends in the development of neutralizing
antibody assays
• Cross-reactivity to endogenous proteins
• Clinical implications of ADAs
CHALLENGES OF
IMMUNOGENICITY ASSESSMENT
November 16, 2015 • 5:30-8:30 p.m. • Hilton Baltimore • Baltimore, MD
Instructors:
Jim McNally, Ph.D.,
Associate Director, PDM Immunogenicity
Expert, EMD Serono
Amy Loercher, Ph.D.,
Manager, Clinical Immunology, GlaxoSmithKline
This interactive session of intermediate level will focus on the potential challenges
of immunogenicity testing in preclinical and clinical development and present case
studies demonstrating how they can be handled. Attendees are encouraged to
contribute with their own experiences and to bring questions for discussion or
submit to the meeting organizers in advance.
NOVEMBER 17-19, 2015
HILTON BALTIMORE
BALTIMORE, MD
This short course is being held at
How to Register: ImmunogenicitySummit.com or call 781-972-5400
Make Plans to Attend the Number 1 Immunogenicity and Bioassay Event in the U.S.
BringingTogether Industry, Academia and Regulatory Authorities. Join over 250 ofYour Peers!